Showing results (71-80 of 459) with videos related to
Sort By:
Pageof 46
Research and Practice in Thrombosis and Haemostasis|June 17, 2025
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of diseaseCornelia Englisch, Roland Jäger, Jasmina Gassner, et al.Haematologica|October 12, 2023
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerCornelia Englisch, Florian Moik, Johannes Thaler, et al.Annals of Hematology|February 3, 2011
Long-term survival of patients with a history of venous thromboembolismSylvia Elisabeth Reitter, Thomas Waldhoer, Michaela Mayerhofer, et al.Annals of Hematology|November 24, 2018
Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosisLena Hell, Cihan Ay, Florian Posch, et al.Journal of Thrombosis and Haemostasis : JTH|May 16, 2025
Bleeding risk and performance of bleeding risk assessment models in patients with venous thromboembolism on anticoagulation: results from the prospective observational bleeding and assess long-term outcomes on health in patients with venous thromboembolism (BACH-VTE) studyTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.Haematologica|May 26, 2018
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancerElla Grilz, Oliver Königsbrügge, Florian Posch, et al.Eclinicalmedicine|September 2, 2025
Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort studyFlorian Moik, Erzsébet Horváth-Puhó, Cihan Ay, et al.Thrombosis and Haemostasis|October 9, 2018
Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with CancerElla Grilz, Florian Posch, Oliver Königsbrügge, et al.Thrombosis Research|April 30, 2013
Response to antiplatelet therapy is independent of endogenous thrombin generation potentialThomas Gremmel, Simon Panzer, Sabine Steiner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2015
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)Florian Posch, Johannes Thaler, Gerhard-Johann Zlabinger, et al.Pageof 46